|
|
News for Healthier Living
HER2-Targeted Therapy Shows Promising Results in Rare Bile Duct Cancers
 Zanidatamab, a bispecific HER2-targeted antibody, delivered clinically meaningful and durable responses for patients with HER2-positive biliary tract cancer (BTC), according to final results from the HERIZON-BTC-01 clinical trial led by researchers at The University of Texas MD Anderson Cancer Center.
November 25, 2025
November 26 2025November 25 2025November 24 2025November 23 2025November 22 2025November 21 2025November 20 2025November 19 2025November 18 2025 - Parental Monitoring Is Linked to Fewer Teen Conduct Problems Despite Genetic Risk
- ASTRO Publishes First Clinical Guideline on Radiation Therapy for Gastric Cancer
- Robert Wood Johnson University Hospital Hamilton Unveils New Helistop
- Helping Parents Bond With Premature Babies in the NICU
- Pediatric Epilepsy Surgery: The Case for Earlier Referral
- SLU Study Links Depression, Insomnia to Higher Risk of Dementia
- SLU, WashU Medicine Research Shows Psychedelic Decriminalization Hasn't Increased ER Visits
- Colorectal Cancer Screenings Remain Low for People Ages 45 to 49 Despite Guideline Change
- New AI Tool Streamlines Workflows in the MD Curriculum
- Yale Study Sheds Light on Cellular Resistance to Osimertinib in Adenocarcinoma
- Improving Immunotherapy Responses by Approaching on Two Fronts
- Simple Screening Tool Can Help Uncover Underdiagnosed Back Condition, Study Finds
- Bridging Biology and AI: Yale and Google's Collaborative Breakthrough in Single-Cell RNA Analysis
- High Rates of Articular Cartilage Damage Found in Pediatric Athletes After ACL Injuries, Meniscus Tears
- Increases in Physician Attrition Rates Could Worsen Shortages
- Uncovering Hidden Risk Factors: Sleep-Related Leg Movements and Diabetes
- Most People with a Genetic Condition That Causes Significantly High Cholesterol Go Undiagnosed, Mayo Clinic Study Finds
- Cedars-Sinai Combats Hunger Crisis
- Veteran Suicide Rates Are Declining, but Remain High for Those with Brain Injuries, Research Shows
- New Law Tightens Hemp Regulations, Threatening 300,000 Jobs
- Morning Workouts Steal Sleep From Student Athletes, Study Finds
- NIH Grant Terminations Leave Thousands Without Access to Care, Study Finds
- New Survey Shows 72% of Adults Struggle With Sleepiness Each Day
- Cold Snaps, Heat Waves Kill Thousands Annually
- Online Tool Helps Younger Adults Plan For Their Long-Term Heart Health
- New AI Might Boost Liver Donations By Highlighting Best Potential Donors
- Drugs Rarely Become Available In Lower-Income Countries Where They're Tested, Study Says
- Agriculture Linked To Melanoma Cluster In Pennsylvania
- Traces Of Bacteria Found In Brain Tumors
- Bone-Targeted Estrogen Delivery Reverses Postmenopausal Osteoporosis in Mice
- Manure Digesters on Farms Carry Limited Benefits and Potential Harms
- Study: New Potential for Gene-Based Treatment for Sepsis and Lung Injury
- New Study Reveals Blueprint of How Super Users Leverage Best Practices to Deliver Virtual Health Care
- Berenson Cancer Center Announces Publication in Haematologica
- Muscle Protein Linked to Exercise Opens New Way to Treat Alzheimer's
- Vanda Pharmaceuticals Reports Positive Results for Tradipitant in Preventing GLP-1 Induced Nausea and Vomiting
- First-of-Its Kind Nationwide Telehealth Therapeutic Clinical Trial for Cancer Now Open at Ohio State
- Targeted Protein Degradation: Researchers Find New Way to Combat Harmful Proteins in Tumour Cells
November 17 2025November 16 2025November 15 2025November 14 2025November 13 2025 - Single-Cell RNA-Seq Reveals the Transcriptional Program Underlying Tumor Progression and Metastasis in Neuroblastoma
- Cardiology Clinic Goes Mobile Serving Those in Need
- NYU Tandon Researchers Quantify Intensity of Emotional Response to Sound, Images and Touch Through Skin Conductance
- 27 YSM Faculty Members Recognized for Highly Cited Research
- Metabolic Hormone Found to Boost Resilience Against Flu Symptoms
- Reversing Fibrosis: New Research Provides Insight for Novel Therapies
- ASH 2025 Posters Preview - Sylvester Researchers Contribute to More Than 100 Poster Presentations in Orlando
- Carve the Turkey, Not Your Hand: Orthopaedic Experts Share Simple Steps to Keep Your Holiday Injury-Free
- Experts Urge Continued Hepatitis B Vaccine Birth Doses for Newborns
- Surgery After Immunotherapy Boosts Survival for Liver Cancer Patients
- New SLU, SSM Study Shows Ozempic Could Help Dialysis Patients Qualify for Kidney Transplants
- New DNA Analysis Approach Could Transform Understanding of Disease Evolution
- Dr. Richard Pazdur Appointed to Lead FDA's Drug Division After Turbulent Year
- Global Tuberculosis Cases Hit Record High, WHO Warns
- Poor Sleep Nearly Doubles a Runner’s Risk of Injury, Study Finds
- New Merck Pill Cuts 'Bad' Cholesterol by 60%, Potentially Replacing Injections
- Study Links Food Insecurity to Tumor Growth in Pediatric Neuroblastoma
- Heart Health Impact Of Food Deserts Can Be Blunted By Healthy Grocery Deliveries, Study Says
- Ultra-Processed Foods Linked To Diabetes Risk In Young Adults
- Headaches Affect Almost a Third of People Worldwide
- High Blood Pressure Rates Double Among Children & Teens
- Poverty, Debt Lead To Early Death In The U.S., Studies Say
- Personalized Prehabilitation Improves Surgery Outcomes, Trial Finds
- Support from Harrington Discovery Institute at University Hospitals Helped Advance Heart Attack Drug into Clinical Trials
- Droplet Biosciences-Study Reveals Post-Surgical Lymph Fluid as a Powerful Source of ctDNA for Early Recurrence Detection in Head & Neck Cancer
- Efficacy of Linaclotide versus Senna as Bowel Preparation Additive and More in the November Issue of the Red Journal
- CT Colonography Most Cost-Effective Colorectal Cancer Screening Strategy for Black Adults
November 12 2025
|
|
|
|
|